TrialJournal of clinical psychopharmacology

A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder: Results of the TERPSIS Study.

Shannon R Benedetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.